Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Mehr anzeigen
-- Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling activities for Wilson’s Disease program in 4Q 2024 and remains on...
CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies...
-- On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prime...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.105 | 3.83211678832 | 2.74 | 3.05 | 2.56 | 1402427 | 2.83826626 | CS |
| 4 | -0.475 | -14.3072289157 | 3.32 | 3.515 | 2.56 | 1264526 | 3.02182771 | CS |
| 12 | -0.585 | -17.055393586 | 3.43 | 4.71 | 2.56 | 1200930 | 3.52266638 | CS |
| 26 | -2.995 | -51.2842465753 | 5.84 | 6.75 | 2.56 | 1224523 | 3.93054229 | CS |
| 52 | -6.575 | -69.7983014862 | 9.42 | 9.8 | 2.56 | 992354 | 5.02525689 | CS |
| 156 | -16.125 | -85.0026357406 | 18.97 | 21.7301 | 2.56 | 648628 | 7.2878939 | CS |
| 260 | -16.125 | -85.0026357406 | 18.97 | 21.7301 | 2.56 | 648628 | 7.2878939 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
